Skip to content

Active ingredient

Dihydroergotamine

15 finished FDA listings contain Dihydroergotamine as their only active ingredient.

FDA NDC Directory

Ingredient names as written by FDA
DIHYDROERGOTAMINE, DIHYDROERGOTAMINE MESYLATE
Dosage forms
Injection, Injection, Solution, Powder, Spray, Spray, Metered
Routes
Intramuscular, Intravenous, Nasal, Subcutaneous
Manufacturers / labelers
13
Strengths listed
1 mg/ml · 4 mg/ml · 5.2 mg/1
Brand names in FDA listings
Atzumi, Brekiya, Trudhesa

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 3418

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

ApplicationSponsorOriginal approvalListings
NDA 020148BAUSCH1997-12-081
ANDA 040453HIKMA2003-06-091
ANDA 206621HIKMA PHARMS2017-09-151
ANDA 212046MILLA PHARMS2020-01-072
ANDA 211393HIKMA2020-02-281
ANDA 212907CIPLA2020-05-201
NDA 213436IMPEL PHARMS2021-09-021
ANDA 216881RUBICON RESEARCH2023-06-222
ANDA 215623GLAND2023-08-181
ANDA 216747BAXTER HLTHCARE CORP2025-01-071
ANDA 215228SOMERSET THERAPS LLC2025-02-261
NDA 217901SATSUMA PHARMS2025-04-301
NDA 215400AMNEAL2025-05-141

Official labeling on DailyMed

Showing the 12 most recent of 15 labels.

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.